01—Abstract
Summary
Summary of the 6-K filed October 25, 2022. Cited figures are marked; the original filing is the authoritative source.
Celestica Inc. has filed a Form 6-K on October 25, 2022, reporting on its financial performance and condition for the three and nine months ended September 30, 2022.
This report primarily includes the Management's Discussion and Analysis (MD&A) and the Unaudited Interim Condensed Consolidated Financial Statements, crucial documents for investors to assess the company's operational and financial health. The filing provides insights into Celestica's financial results, operational strategies, and outlook.
Investors should pay close attention to the details within the MD&A and financial statements to understand revenue trends, profitability, liquidity, and any significant risks or uncertainties the company may be facing. The inclusion of Sarbanes-Oxley certifications further underscores the company's commitment to financial transparency and regulatory compliance.
02—Key points
Key Highlights
- Filing Date: October 25, 2022.
- Report Type: Form 6-K (Report of Foreign Private Issuer).
- Reporting Period: Three and nine months ended September 30, 2022.
- Key Documents Included: Management's Discussion and Analysis (MD&A) and Unaudited Interim Condensed Consolidated Financial Statements.
- Incorporation by Reference: Information from exhibits is incorporated into effective registration statements.
- Sarbanes-Oxley Certifications: CEO and CFO certifications provided under Sections 302 and 906.
03—Questions
Frequently Asked Questions
What is the primary purpose of this Form 6-K filing for Celestica Inc.?
The primary purpose of this Form 6-K filing is to provide investors with updated financial information, specifically the Management's Discussion and Analysis (MD&A) and the Unaudited Interim Condensed Consolidated Financial Statements for the third quarter and the first nine months of 2022. As a foreign private issuer, Celestica uses this form to report material information to the SEC.
What key financial information can investors find in the referenced exhibits?
Investors can find detailed insights into Celestica's financial performance, including revenue, profitability, cost of goods sold, operating expenses, and net income. The MD&A will discuss significant trends, factors affecting results, liquidity, capital resources, and any known trends or uncertainties. The financial statements will provide the quantitative data, including balance sheets, income statements, and cash flow statements.
Why are Sarbanes-Oxley certifications included in this filing?
The inclusion of CEO and CFO certifications under Sections 302 and 906 of the Sarbanes-Oxley Act (SOX) demonstrates the company's commitment to certifying the accuracy and completeness of its financial reports. This is a standard requirement for U.S. public companies and foreign private issuers listing on U.S. exchanges, aimed at enhancing corporate accountability and financial transparency.
04—Continue